CVRx, Inc. Proceeds from Long-term Lines of Credit
CVRx, Inc. (CVRX) reported Proceeds from Long-term Lines of Credit of $10.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromLongTermLinesOfCredit · last filed 2026-08-06
- CVRx, Inc. proceeds from long-term lines of credit for the quarter ending 2026-06-30 was $0.00.
- CVRx, Inc. proceeds from long-term lines of credit for the quarter ending 2026-03-31 was $10.00M.
- CVRx, Inc. proceeds from long-term lines of credit for the quarter ending 2025-12-31 was $0.00.
- CVRx, Inc. proceeds from long-term lines of credit for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- CVRx, Inc. proceeds from long-term lines of credit for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- CVRx, Inc. proceeds from long-term lines of credit for fiscal 2024 was $20.00M, a 11.11% decline from fiscal 2023.
- CVRx, Inc. proceeds from long-term lines of credit for fiscal 2023 was $22.50M, a 200.00% increase from fiscal 2022.
- CVRx, Inc. proceeds from long-term lines of credit for fiscal 2022 was $7.50M.
| Period end | Proceeds from Long-term Lines of Credit 3 month | Proceeds from Long-term Lines of Credit 6 month | Proceeds from Long-term Lines of Credit 9 month | Proceeds from Long-term Lines of Credit 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $10.00M 10-Q · filed 2026-08-06 | $10.00M derived: sum of 3 quarters · filed 2026-08-06 | $10.00M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $10.00M 10-Q · filed 2026-05-12 | $10.00M derived: sum of 2 quarters · filed 2026-05-12 | $10.00M derived: sum of 3 quarters · filed 2026-05-12 | $10.00M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $0.00 derived: sum of 2 quarters · filed 2026-02-13 | $0.00 derived: sum of 3 quarters · filed 2026-08-06 | $0.00 10-K · filed 2026-02-13 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2026-08-06 | $0.00 10-Q · filed 2025-11-06 | $0.00 derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $0.00 10-Q · filed 2026-08-06 | $0.00 derived: sum of 3 quarters · filed 2026-08-06 | $20.00M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-12 | $0.00 derived: sum of 2 quarters · filed 2026-05-12 | $20.00M derived: sum of 3 quarters · filed 2026-05-12 | $20.00M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $20.00M derived: sum of 2 quarters · filed 2026-02-13 | $20.00M derived: sum of 3 quarters · filed 2026-02-13 | $20.00M 10-K · filed 2026-02-13 |
| 2024-09-30 | $20.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $20.00M derived: sum of 2 quarters · filed 2025-11-06 | $20.00M 10-Q · filed 2025-11-06 | $35.00M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $0.00 10-Q · filed 2024-08-02 | $15.00M derived: sum of 3 quarters · filed 2025-02-18 | $15.00M derived: sum of 4 quarters · filed 2025-02-18 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-10 | $15.00M derived: sum of 2 quarters · filed 2025-02-18 | $15.00M derived: sum of 3 quarters · filed 2025-02-18 | $15.00M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-12-31 | $15.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $15.00M derived: sum of 2 quarters · filed 2025-02-18 | $15.00M derived: sum of 3 quarters · filed 2025-02-18 | $22.50M 10-K · filed 2025-02-18 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-01 | $0.00 derived: sum of 2 quarters · filed 2024-11-01 | $7.50M 10-Q · filed 2024-11-01 | $15.00M derived: sum of 4 quarters · filed 2024-11-01 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $7.50M 10-Q · filed 2024-08-02 | $15.00M derived: sum of 3 quarters · filed 2024-08-02 | $15.00M derived: sum of 4 quarters · filed 2024-08-02 |
| 2023-03-31 | $7.50M 10-Q · filed 2024-05-10 | $15.00M derived: sum of 2 quarters · filed 2024-05-10 | $15.00M derived: sum of 3 quarters · filed 2024-05-10 | $15.00M derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $7.50M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-09 | $7.50M derived: sum of 2 quarters · filed 2024-02-09 | $7.50M derived: sum of 3 quarters · filed 2024-02-09 | $7.50M 10-K · filed 2024-02-09 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-31 | $0.00 derived: sum of 2 quarters · filed 2023-10-31 | $0.00 10-Q · filed 2023-10-31 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $0.00 10-Q · filed 2023-08-03 | ||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-11 | |||
| 2021-12-31 | $0.00 10-K · filed 2023-02-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |